| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |